• Deferasirox Alters Myeloid Differentiation via NF-κB and ROS

  2026-06-03

  This study demonstrates that Deferasirox, a clinical iron chelator, modulates myeloid cell differentiation by altering mitochondrial ROS and NF-κB activity in both human and murine models. The findings offer mechanistic insight into hematologic improvements seen in iron overload disorders and highlight stage-dependent effects on progenitor versus mature myeloid cells.

• Resazurin sodium salt (SKU B6098): Reliable Solutions for Ce

  2026-06-02

  This scenario-driven article explores common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Resazurin sodium salt (SKU B6098) delivers robust, reproducible results. Practical Q&A blocks address experimental design, protocol optimization, and data interpretation, with evidence-based recommendations and cross-references to major studies and product specifications. APExBIO’s Resazurin sodium salt is highlighted for its sensitivity, workflow compatibility, and reliability in demanding research contexts.

• (R,S)-Anatabine Workflows: Applied Use in Alzheimer's Models

  2026-06-02

  (R,S)-Anatabine, a potent amyloid-beta inhibitor, enables precision targeting of soluble Aβ peptide reduction and neuroinflammatory pathways in Alzheimer's research. This guide delivers actionable protocols and troubleshooting insights, positioning APExBIO's compound as a gold standard for both in vitro and in vivo model optimization.

• Calcium’s Modulation of Amyloid Beta (1-40) Aggregation at M

  2026-06-01

  This study leverages supercritical angle Raman and fluorescence spectroscopy to dissect how calcium ions influence amyloid beta-peptide (1-40) aggregation at lipid membrane interfaces. The findings clarify calcium’s nuanced protective and disruptive roles during amyloid aggregation, informing experimental design and potential therapeutic targeting in Alzheimer's disease research.

• Lyotropic Phase Behavior of Coil-Bottlebrush Diblocks in Ion

  2026-06-01

  This study systematically investigates how coil-bottlebrush diblock copolymers self-assemble in alkylimidazolium-based ionic liquids, revealing that three-dimensional network morphologies exhibit remarkable insensitivity to variations in the ionic liquid’s alkyl chain length. These findings broaden the design space for advanced nanomaterials by decoupling network formation from strict solvent structure requirements.

• E-64d: Precision Cysteine Protease Inhibition in Cell Death

  2026-05-31

  E-64d, a membrane-permeable cysteine protease inhibitor from APExBIO, empowers researchers to dissect regulated cell death pathways with high specificity and reproducibility. This article details experimental workflows, troubleshooting strategies, and the translational impact of E-64d in apoptosis and lysoptosis research, underpinned by the latest evidence.

• Biotin (Vitamin B7): Molecular Mechanisms and Assay Innovati

  2026-05-30

  Explore the unique molecular roles of Biotin (Vitamin B7) as both a metabolic coenzyme and a precision labeling reagent. This article unveils advanced mechanistic insights and assay strategies, setting a new benchmark for scientific research applications.

• n-Dodecyl-β-D-maltoside: Optimizing Membrane Protein Purific

  2026-05-29

  n-Dodecyl-β-D-maltoside (DDM) is a cornerstone detergent for membrane protein research, enabling efficient solubilization and stabilization of complex protein assemblies. This guide details practical protocols, advanced use-cases, and troubleshooting tips that leverage DDM’s unique properties for reliable experimental outcomes.

• SC 79 Akt Activator: Mechanism, Evidence & Neuroprotection I

  2026-05-29

  SC 79 is a potent and selective small molecule Akt activator with demonstrated efficacy in neuroprotection and cell survival models. Its unique mechanism—binding to the Akt PH domain in the cytosol—enables robust, membrane-independent activation of Akt. Published evidence supports SC 79’s use in ischemic stroke, neuronal survival, and Akt signaling pathway research.

• RG7388 and MDM2 Antagonism: Precision in p53 Pathway Modulat

  2026-05-28

  Explore how RG7388, a potent MDM2 antagonist, enables precise p53 pathway activation and apoptosis in cancer cells. This article provides a deeper, evidence-driven perspective on optimizing assay design and interpreting chemoradiotherapy sensitivity using the latest molecular insights.

• Obacunone Attenuates Neuroinflammation After Spinal Cord Inj

  2026-05-28

  This study demonstrates that obacunone, a natural limonoid, significantly reduces neuroinflammation and apoptosis following spinal cord injury by inhibiting the TLR4/MyD88/p38 MAPK pathway. The findings suggest a promising therapeutic avenue for improving neural repair and functional recovery in CNS trauma.

• Sulfo-NHS-LC-Biotin: Practical Guide for Protein Biotinylati

  2026-05-27

  Sulfo-NHS-LC-Biotin addresses the need for selective, covalent biotin labeling of cell surface and soluble proteins in aqueous environments, eliminating the use of organic solvents. It should be used for extracellular or membrane protein biotinylation workflows, not for reversible or intracellular applications due to its membrane-impermeable and irreversible nature.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Pr

  2026-05-27

  DiI (DiIC18(3)) provides high-contrast, selective plasma membrane labeling for live and fixed cells, essential for neuronal tracing and membrane-specific assays. It is unsuitable for water-based protocols or intracellular organelle targeting, requiring precise solvent and workflow choices for reliable membrane staining.

• O-GlcNAcylation Links Wnt Signaling to Bone Anabolism via Gl

  2026-05-26

  The referenced study uncovers a mechanistic pathway in which Wnt3a-induced O-GlcNAcylation is essential for osteoblast differentiation and bone formation, acting through metabolic reprogramming of glycolysis. These findings clarify how post-translational modification integrates Wnt signaling and glucose metabolism, with practical implications for bone disease research and therapeutic development.

• Toremifene Citrate: Precision Dose-Response in Estrogen Rece

  2026-05-26

  Explore how Toremifene Citrate, a leading oral selective estrogen receptor modulator, enables nuanced, quantitative investigation of estrogen receptor signaling and breast cancer proliferation. This article uniquely emphasizes dose-response optimization and methodological rigor for advanced research applications.

407 records 13/28 page Previous Next First page 上5页 1112131415 下5页 Last page